Addex Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ADXN and other ETFs, options, and stocks.

About ADXN

Addex Therapeutics Ltd. is a biopharmaceutical company, which engages in the development of drugs for human health. It develops novel, orally available, and small molecule allosteric modulators for neurological disorders. 

CEO
Timothy Dyer
CEOTimothy Dyer
Employees
2
Employees2
Headquarters
Geneva, Geneve (Geneva)
HeadquartersGeneva, Geneve (Geneva)
Founded
2002
Founded2002
Employees
2
Employees2

ADXN Key Statistics

Market cap
14.00M
Market cap14.00M
Price-Earnings ratio
-1.06
Price-Earnings ratio-1.06
Dividend yield
Dividend yield
Average volume
13.73K
Average volume13.73K
High today
$8.55
High today$8.55
Low today
$7.94
Low today$7.94
Open price
$7.94
Open price$7.94
Volume
8.29K
Volume8.29K
52 Week high
$12.05
52 Week high$12.05
52 Week low
$6.51
52 Week low$6.51

Stock Snapshot

As of today, Addex Therapeutics(ADXN) shares are valued at $8.53. The company's market cap stands at 14M, with a P/E ratio of -1.06.

On 2025-12-04, Addex Therapeutics(ADXN) stock moved within a range of $7.94 to $8.55. With shares now at $8.53, the stock is trading +7.4% above its intraday low and -0.2% below the session's peak.

Trading volume for Addex Therapeutics(ADXN) stock has reached 8.29K, versus its average volume of 13.73K.

Over the past 52 weeks, Addex Therapeutics(ADXN) stock has traded between a high of $12.05 and a low of $6.51.

Over the past 52 weeks, Addex Therapeutics(ADXN) stock has traded between a high of $12.05 and a low of $6.51.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.